Knight Therapeutics, Inc. announced the Canadian commercial availability of IBSRELA, a first-in-class therapy for the treatment of IBS with constipation in adults.
[Knight Therapeutics Inc.]
6445212
{6445212:nan}
apa
50
1
159789
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
